Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.

Among all US adults, salt substitute use remained low, peaking at 5.4% in 2013 to 2014 and dropping to 2.5% by 2017 to March 2020.

HealthDay News — The U.S. No Surprises Act (NSA) reduced patients’ out-of-pocket spending for medical care, according to a study published online Aug. 27 in The BMJ.

A new pediatric asthma attack prediction model combines data on attack history, salivary bacteria composition, and serum inflammatory mediator levels.

Women with systemic sclerosis face increased risks for APOs, with certain risks being elevated even before diagnosis.

Depression symptoms and reduced lung function are common among individuals exposed to the August 2023 Maui wildfires.

HealthDay News — More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in Cancer.

For adults with a history of smoking undergoing low-dose CT for lung cancer screening, emphysema is predictive of mortality up to 25 years.

Topline data were announced from a phase 3 trial evaluating Merck’s 21-valent pneumococcal conjugate vaccine, Capvaxive, in pediatric and adolescent patients.

The FDA released draft guidance to advance safe and effective nonopioid treatment options and reduce risks tied to ...

Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

HealthDay News — Meal timing changes with age and may reflect health changes in older adults, according to a study published online Sept. 4 in Communications Medicine.